Overview
Thomas Mir practices in Hamburg, Germany. Mr. Mir is rated as an Advanced expert by MediFind in the treatment of Sinus of Valsalva Aneurysm. His top areas of expertise are Marfan Syndrome, Sinus of Valsalva Aneurysm, Mitral Valve Prolapse, and MASS Phenotype.
His clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Sinus of Valsalva Aneurysm.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Marfan SyndromeMr. Mir isDistinguished. Learn about Marfan Syndrome.
- Advanced
- Congenital Contractural Arachnodactyly
- MASS PhenotypeMr. Mir isAdvanced. Learn about MASS Phenotype.
- Mitral Valve ProlapseMr. Mir isAdvanced. Learn about Mitral Valve Prolapse.
- Sinus of Valsalva AneurysmMr. Mir isAdvanced. Learn about Sinus of Valsalva Aneurysm.
- Experienced
- Achard SyndromeMr. Mir isExperienced. Learn about Achard Syndrome.
- Aortic DissectionMr. Mir isExperienced. Learn about Aortic Dissection.
- ArachnodactylyMr. Mir isExperienced. Learn about Arachnodactyly.
- Bicuspid Aortic ValveMr. Mir isExperienced. Learn about Bicuspid Aortic Valve.
- Congenital Cardiovascular ShuntMr. Mir isExperienced. Learn about Congenital Cardiovascular Shunt.
- Ebstein's AnomalyMr. Mir isExperienced. Learn about Ebstein's Anomaly.